Pulmonary medicine
Pro Research Analysisby 
Searched over 200M research papers for "pulmonary medicine"
Advances in Pulmonary Medicine: Disease Focus and Pathophysiology
Pulmonary medicine covers a wide range of respiratory diseases, including interstitial lung disease (ILD), idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), pulmonary hypertension (PH), sarcoidosis, eosinophilic pneumonia, asthma, and lung cancer. Recent research has highlighted the importance of understanding both the basic mechanisms and clinical management of these conditions. For example, autophagy—a cellular process for maintaining homeostasis—has been shown to play a protective role in IPF but may contribute to COPD progression. The role of autophagy in PH and asthma remains unclear, with studies showing conflicting results .
Epigenetic changes, such as DNA methylation and histone modification, are increasingly recognized as important in the development and progression of COPD, IPF, and PH. These mechanisms may also help improve early diagnosis and treatment, especially for ILD and IPF, which have poor survival rates .
Pulmonary Hypertension and Interstitial Lung Disease: Diagnosis and Treatment
Pulmonary hypertension is a common and serious complication in patients with chronic lung diseases like COPD and ILD. It is associated with worse outcomes and higher mortality. Accurate diagnosis is challenging and often requires echocardiography and right heart catheterization in select cases. The mainstay of treatment for hypoxemic patients is long-term oxygen therapy and pulmonary rehabilitation. Lung transplantation remains the only curative option for advanced cases. While vasodilator drugs are not recommended for mild-to-moderate PH due to lack of efficacy and potential harm, inhaled treprostinil has shown promise in improving function and delaying worsening in ILD patients with PH Carbone2025Wouters2018.
Artificial Intelligence and Imaging in Pulmonary Medicine
Artificial intelligence (AI) is transforming pulmonary healthcare by improving diagnostic accuracy and enabling personalized treatment. Deep learning algorithms, such as those based on international guidelines for IPF, have been shown to enhance the evaluation of high-resolution computed tomography (HRCT) scans, leading to better diagnosis and management of ILD. AI-driven tools are also being developed for other respiratory diseases, but challenges remain regarding data quality, privacy, and regulatory oversight Carbone2025Leon-Astudillo2024.
Pediatric Pulmonary Medicine: Key Disorders and Multidisciplinary Care
In infants, respiratory disorders such as bronchopulmonary dysplasia, diffuse lung disease, pulmonary hypertension, and sleep apnea require specialized care. Multidisciplinary approaches involving pediatric pulmonologists, sleep clinicians, and neonatologists are essential for optimal outcomes. Advances in genetic testing, imaging, and treatment modalities are improving the evaluation and management of these conditions .
Drug Delivery and Therapeutic Strategies in Pulmonary Diseases
Effective drug delivery is crucial for treating pulmonary diseases. Inhaled therapies are preferred for many conditions, but rapid clearance from the lungs can limit their effectiveness. New strategies, including nanoparticles, microparticles, liposomes, and microemulsions, are being developed to extend pulmonary exposure and improve outcomes. These innovations must balance safety, efficacy, and manufacturability to meet regulatory standards Ahmed2024Bickton2020.
The Role of Multidisciplinary Teams in Pulmonary Care
Collaboration between respiratory therapists, nurses, and other healthcare professionals is vital for managing chronic respiratory diseases like COPD, asthma, and acute respiratory distress syndrome (ARDS). Effective teamwork leads to comprehensive care plans, better patient education, and improved health outcomes .
Personalized Medicine and Comorbidities in Pulmonary Rehabilitation
COPD and other chronic lung diseases often coexist with comorbidities such as cardiovascular disease, osteoporosis, and impaired muscle function. Personalized rehabilitation programs that address these comorbidities and promote physical activity are essential for improving quality of life and disease outcomes .
Conclusion
Pulmonary medicine is rapidly evolving, with advances in understanding disease mechanisms, improving diagnostic tools, and developing innovative therapies. Multidisciplinary care, personalized medicine, and technological innovations like AI are shaping the future of respiratory healthcare. Continued research and collaboration are needed to further improve outcomes for patients with pulmonary diseases Carbone2025Leon-Astudillo2024Thakur2020+5 MORE.
Sources and full results
Most relevant research papers on this topic
ATS core curriculum 2023. Pediatric pulmonary medicine: Respiratory disorders in infants
The Pediatric Pulmonary Medicine Core Curriculum highlights the importance of multidisciplinary care for infants with respiratory disorders, emphasizing genetic testing, novel imaging, and treatment modalities.
Breathing Easy: The Combined Efforts of Respiratory Therapists and Nurses in Pulmonary Care
Collaborative efforts between respiratory therapists and nurses in pulmonary care can improve patient outcomes and satisfaction by enhancing communication, role delineation, and technological advancements.
Personalised pulmonary rehabilitation in COPD
Pulmonary rehabilitation offers a comprehensive, individualised approach for personalised management of COPD patients, considering unique circumstances and enhancing doctor-patient relationships.
Evidence for pulmonary rehabilitation in chronic respiratory diseases in sub-Saharan Africa: a systematic review.
Pulmonary rehabilitation shows limited evidence in sub-Saharan Africa, but data support its use for various chronic respiratory conditions.
DOI